Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040050813> ?p ?o ?g. }
- W2040050813 endingPage "1600" @default.
- W2040050813 startingPage "1589" @default.
- W2040050813 abstract "Doxorubicin (DOX) is a key chemotherapeutic drug for cancer treatment. The antitumor mechanism of DOX is its action as a topoisomerase II poison by preventing DNA replication. Our study shows that DOX can be involved in epigenetic regulation of gene transcription through downregulation of DNA methyltransferase 1 (DNMT1) then reactivation of DNA methylation-silenced tumor suppressor genes in glioblastoma (GBM). Recent evidence demonstrated that microRNA (miR or miRNA) can mediate expression of genes through post-transcriptional regulation and modulate sensitivity to anticancer drugs. As one of the first miRNAs detected in the human genome, miR-21 has been validated to be overexpressed in GBM. Combination treatment of a chemotherapeutic and miRNA showed synergistically increased anticancer activities which has been proven to be an effective strategy for tumor therapy. In our study, co-treatment of DOX and miR-21 inhibitor (miR-21i) resulted in remarkably increased expression of tumor suppressor genes compared with DOX or the miR-21i treatment alone. Moreover, we demonstrate that combining DOX and miR-21i significantly reduced tumor cell proliferation, invasion and migration in vitro. Our study concludes that combining DOX and miR-21i is a new strategy for the therapy of GBM." @default.
- W2040050813 created "2016-06-24" @default.
- W2040050813 creator A5006630986 @default.
- W2040050813 creator A5007814846 @default.
- W2040050813 creator A5016196534 @default.
- W2040050813 creator A5039882839 @default.
- W2040050813 creator A5041883076 @default.
- W2040050813 creator A5047485845 @default.
- W2040050813 creator A5058481549 @default.
- W2040050813 creator A5060461941 @default.
- W2040050813 date "2015-01-22" @default.
- W2040050813 modified "2023-10-12" @default.
- W2040050813 title "Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes" @default.
- W2040050813 cites W144423133 @default.
- W2040050813 cites W1566823022 @default.
- W2040050813 cites W1602172318 @default.
- W2040050813 cites W1616307661 @default.
- W2040050813 cites W1831033366 @default.
- W2040050813 cites W1964081206 @default.
- W2040050813 cites W1970760326 @default.
- W2040050813 cites W1974758811 @default.
- W2040050813 cites W1978177843 @default.
- W2040050813 cites W1980157504 @default.
- W2040050813 cites W1985450307 @default.
- W2040050813 cites W1988628426 @default.
- W2040050813 cites W1989421786 @default.
- W2040050813 cites W1994233351 @default.
- W2040050813 cites W2003438982 @default.
- W2040050813 cites W2006535551 @default.
- W2040050813 cites W2016273963 @default.
- W2040050813 cites W2032563823 @default.
- W2040050813 cites W2036982851 @default.
- W2040050813 cites W2043933892 @default.
- W2040050813 cites W2045218593 @default.
- W2040050813 cites W2048910343 @default.
- W2040050813 cites W2049767158 @default.
- W2040050813 cites W2054807590 @default.
- W2040050813 cites W2054823635 @default.
- W2040050813 cites W2061543625 @default.
- W2040050813 cites W2064871082 @default.
- W2040050813 cites W2074051915 @default.
- W2040050813 cites W2075543095 @default.
- W2040050813 cites W2079613111 @default.
- W2040050813 cites W2084976536 @default.
- W2040050813 cites W2085642771 @default.
- W2040050813 cites W2087527154 @default.
- W2040050813 cites W2088170612 @default.
- W2040050813 cites W2092536854 @default.
- W2040050813 cites W2097617161 @default.
- W2040050813 cites W2102627944 @default.
- W2040050813 cites W2104610341 @default.
- W2040050813 cites W2106523925 @default.
- W2040050813 cites W2106566926 @default.
- W2040050813 cites W2110789683 @default.
- W2040050813 cites W2117282329 @default.
- W2040050813 cites W2121010151 @default.
- W2040050813 cites W2121417064 @default.
- W2040050813 cites W2122347701 @default.
- W2040050813 cites W2123014125 @default.
- W2040050813 cites W2124288132 @default.
- W2040050813 cites W2126287587 @default.
- W2040050813 cites W2126305313 @default.
- W2040050813 cites W2127667644 @default.
- W2040050813 cites W2129437923 @default.
- W2040050813 cites W2132243179 @default.
- W2040050813 cites W2163325084 @default.
- W2040050813 cites W2163655902 @default.
- W2040050813 cites W2168917123 @default.
- W2040050813 doi "https://doi.org/10.3892/ijo.2015.2841" @default.
- W2040050813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25625875" @default.
- W2040050813 hasPublicationYear "2015" @default.
- W2040050813 type Work @default.
- W2040050813 sameAs 2040050813 @default.
- W2040050813 citedByCount "32" @default.
- W2040050813 countsByYear W20400508132015 @default.
- W2040050813 countsByYear W20400508132016 @default.
- W2040050813 countsByYear W20400508132017 @default.
- W2040050813 countsByYear W20400508132018 @default.
- W2040050813 countsByYear W20400508132020 @default.
- W2040050813 countsByYear W20400508132021 @default.
- W2040050813 countsByYear W20400508132022 @default.
- W2040050813 countsByYear W20400508132023 @default.
- W2040050813 crossrefType "journal-article" @default.
- W2040050813 hasAuthorship W2040050813A5006630986 @default.
- W2040050813 hasAuthorship W2040050813A5007814846 @default.
- W2040050813 hasAuthorship W2040050813A5016196534 @default.
- W2040050813 hasAuthorship W2040050813A5039882839 @default.
- W2040050813 hasAuthorship W2040050813A5041883076 @default.
- W2040050813 hasAuthorship W2040050813A5047485845 @default.
- W2040050813 hasAuthorship W2040050813A5058481549 @default.
- W2040050813 hasAuthorship W2040050813A5060461941 @default.
- W2040050813 hasBestOaLocation W20400508131 @default.
- W2040050813 hasConcept C104317684 @default.
- W2040050813 hasConcept C121608353 @default.
- W2040050813 hasConcept C127561419 @default.
- W2040050813 hasConcept C145059251 @default.
- W2040050813 hasConcept C147897179 @default.
- W2040050813 hasConcept C150194340 @default.